Type 2 diabetes: your GLP-1 path skips the Bridge — and that's usually good news
Short answer: If you have type 2 diabetes, you're excluded from the Medicare GLP-1 Bridge — because Medicare already covers GLP-1 medications like Ozempic and Mounjaro for diabetes under standard Part D. That path is often better than the Bridge: Extra Help applies, your payments count toward the annual out-of-pocket cap, and there are no BMI tiers.
Program facts last verified against CMS: July 21, 2026
How the Part D diabetes path works
GLP-1s have been covered diabetes treatments for years. Your Part D or Medicare Advantage drug plan lists specific GLP-1s on its formulary — commonly Ozempic, Mounjaro, Rybelsus, or Trulicity — usually with prior authorization and sometimes step therapy (trying metformin or another agent first). Copays vary by plan and tier, but unlike the Bridge's flat $50, these payments count toward the annual out-of-pocket cap (about $2,100 in 2026), after which covered drugs cost you nothing for the rest of the year.
If you also have Extra Help (the Low-Income Subsidy), it applies on this path — it does not apply in the Bridge. For lower-income beneficiaries with diabetes, the Part D route can cost far less than $50 a month.
If your plan denies or its formulary is weak
Formularies differ meaningfully on GLP-1 coverage and restrictions. If your current plan denies coverage or charges a high tier, two levers exist: the plan's exception/appeal process (your prescriber requests coverage based on medical need), and Open Enrollment (October 15 – December 7), when you can switch to a plan whose formulary treats your medication better. Comparing formularies before AEP is one of the highest-value hours a Medicare member with diabetes can spend.
Take the full 2-minute eligibility check →
Common questions
Why am I excluded from the Bridge if I have diabetes?
Because Medicare already covers GLP-1s for diabetes under standard Part D. The Bridge exists specifically for weight-loss use, which Part D historically couldn't cover.
Can I get Wegovy or Zepbound with type 2 diabetes?
Those specific products are approved for weight loss and other indications rather than diabetes; the diabetes path typically covers Ozempic, Mounjaro, and similar. Your prescriber determines the clinically appropriate product, and your plan's formulary determines coverage.
Is the Part D path cheaper than $50/month?
Often, over a full year — payments count toward the out-of-pocket cap (unlike the Bridge's $50), and Extra Help applies if you qualify for it. High-deductible months early in the year can cost more, though; the comparison depends on your plan.
Related
Criteria source: CMS — Medicare GLP-1 Bridge · KFF